OCGN - Ocugen Inc. (OCGN) Q1 2024 Earnings Call Transcript
2024-05-14 13:39:08 ET
Ocugen, Inc. (OCGN)
Q1 2024 Earnings Conference Call
May 14, 2024, 8:30 am ET
Company Participants
Tiffany Hamilton - Head, Corporate Communications
Shankar Musunuri - Chairman, CEO & Co-Founder
Michael Breininger - Corporate Controller
Arun Upadhyay - CSO, Head R&D
Huma Qamar - CMO
Conference Call Participants
Arthur He - H.C. Wainwright
Robert LeBoyer - Noble Capital Markets
Daniil Gataulin - Chardan
Presentation
Operator
Good morning, and welcome to Ocugen's First Quarter 2024 Financial Results and Business Update. Please note that this call is being recorded. At this time, all participants' lines are in listen-only mode. Following the speakers' commentary, there will be a question-and-answer session.
I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate Communications. You may begin.
Tiffany Hamilton
Thank you, operator, and good morning, everyone. Joining me on today's call and webcast is Dr. Shankar Musunuri, Ocugen's Chairman, CEO, and Co-Founder, who will provide a business update and an overview of our clinical and operational progress; Michael Breininger, our Corporate Controller, is also on the call to provide a financial update for the quarter ended March 31, 2024; Dr. Arun Upadhyay, Chief Scientific Officer, Head of Research and Development; and Dr. Huma Qamar, Chief Medical Officer will be available to answer questions following the presentation....
Ocugen, Inc. (OCGN) Q1 2024 Earnings Call Transcript